Skip to main content
The Egyptian Journal of Bronchology
Download PDF
  • Original article
  • Open access
  • Published:

Total antioxidant capacity as a marker in predicting severity of chronic obstructive pulmonary diseases

Egyptian Journal of Bronchology volume 11, pages 322–326 (2017)Cite this article

Abstract

Background

The pathogenesis of chronic obstructive pulmonary disease (COPD) is multifactorial; oxidative stress is suggested to be one of the pathogenetic factors.

Objective

The aim of this study was to assess the role of antioxidant status in pathogenesis of COPD and in predicting the severity of airway obstruction.

Patients and methods

This case-controlled study was carried on 60 patients with COPD, and on 15 apparently healthy age-matched smokers and 15 apparently healthy age-matched nonsmokers, which served as control groups. Bronchoscopy with bronchoalveolar lavage was carried out for 10 COPD patients. Chest radiography, pulmonary function testing, and arterial blood gases were carried out for all groups. Serum level of total antioxidant (TAO) was also measured in all groups by using the enzyme-linked immunosorbent assay kit.

Results

Serum TAO level was significantly reduced in COPD patients and healthy smokers compared with healthy nonsmokers (P<0.001, respectively); moreover, serum TAO level was significantly reduced in COPD compared with healthy smokers (P<0.001), and serum TAO was significantly reduced in severe and very severe COPD compared with mild and moderate COPD (P=0.01 and 0.006, respectively). TAO level significantly negatively correlated with each of PaCO2 and HCO3 in COPD patients, and it was significantly positively correlated with each of forced expiratory volume in 1 s/forced vital capacity and forced expiratory volume in 1 s %. TAO had a sensitivity and specificity of 86.67 and 93.33, respectively, as a biomarker for identification and predicting the severity of COPD with an area under the curve of 0.921.

Conclusion

Serum TAO is a valuable biomarker in identifying and predicting the severity of COPD.

References

  1. GOLD. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLD; 2016.

  2. Yoshida T, Tuder RM. Pathobiology of cigarette smoke induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87:1047–1082.

    Article  CAS  Google Scholar 

  3. Anderson D, Macnee W. Targeted treatment in COPD: a multi-system approach for a multi-system disease. Int J Chron Obstruct Pulmon Dis 2009; 4:321–325.

    Article  CAS  Google Scholar 

  4. Tavilani H, Nadi E, Karimi J, Taghi M. Oxidative stress in COPD patients, smokers, and non-smokers. Respir Care 2012; 57:2090–2094.

    PubMed  Google Scholar 

  5. Zeng M, Li Y, Jiang Y, Lu G, Huang X, Guan K. Local and systemic oxidative stress and glucocorticoid receptor in chronic obstructive pulmonary disease patients. Can Respir J 2012: 35–41.

  6. Van Eeden SF, Leipsic J, Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 2012; 186:11–16.

    Article  Google Scholar 

  7. Kido T, Tamagawa E, Bai N, Suda K, Yang HH, Li Y, et al. Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol Biol 2011; 44:197–204.

    Article  CAS  Google Scholar 

  8. Abdel-Wahab BA, Salama RH. Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice. Pharmacol Biochem Behav 2011; 100:59–65.

    Article  CAS  Google Scholar 

  9. Vestbo J, Hurd S, Agustí A, Jones P, Vogelmeier C, Anzueto A. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2012; 176:532–555.

    Google Scholar 

  10. Pallasaho P, Meren M, Raukas-Kivioja A, Rönmark E. Not 15 but 50% of smokers develop COPD? Report from the obstructive lung disease in northern Sweden studies. Respir Med 2003; 97:8.

    Google Scholar 

  11. Burney PGJ, Patel J, Newson R, Minelli C, Naghavi M. Global and regional trends in COPD mortality, 1990–2010, Eur Respir J 2015; 45:1239–1247.

  12. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease, Lancet 2015; 378:1015–1026.

  13. Ambade V, Sontakka A, Basannar D. Total antioxidant capacity: Correlation with other antioxidants and clinical utility of their levels in chronic obstructive pulmonary disease. Int J Biochem Res Rev 2014; 4:150–162.

    Article  Google Scholar 

  14. Mohamed NA, EL-Deek SEM, Makhlouf HA, Ahmed Y, EL-Metwaly T. Role of hypoxia inducible factor-1α, vascular endothelial growth factor and total antioxidant capacity in chronic obstructive pulmonary disease. Med J Cairo Univ 2015; 8:435–441.

    Google Scholar 

  15. Emin S, Yordanoval K, Dimov D, Vlaykova T. Total antioxidant determined as ferrous reducing ability of plasma in patients with COPD. Trakia J Sci. 2010; 8:205–213.

  16. Rahman I,Swarska E,Henry M,MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2010; 55:189–193.

    Article  Google Scholar 

  17. Sahin U, Unlu M, Ozguner F, Sutcu R, Akkaya A, Delibas N. Lipid peroxidation and glutathione peroxidase activity in chronic obstructive pulmonary disease exacerbation prognostic value of malondialdehyde. J Basic Clin Physiol Pharmacol 2001; 12:59–68.

    Article  CAS  Google Scholar 

  18. Olivieri S, Conti A, Iannaccone S, Cannistraci C, Campanella A, Barbariga M, et al. Ceruloplasmin oxidation, a feature of Parkinson’s disease CSF, inhibit ferrooxidase activity and promotes cellular iron retention. J Neurosci 2011; 31:18568–18577.

    Article  CAS  Google Scholar 

  19. Salvi S, Barnes PJ. Chronic obstructive pulmonary disease in non smokers. Lancet 2009; 374:733–743.

    Article  Google Scholar 

  20. Kontakiotis T, Katsoulis K, Hagizisi O, Kougioulis M, Gerou S, Papakosta D. Bronchoalveolar lavage fluid alteration in antioxidant and inflammatory status in lung cancer patients. Eur J Intern Med 2011; 22:522–526.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Chest, Faculty of Medicine, Assiut University Hospital, Assiut University, Assiut, 71111, Egypt

    Ragaa H. M. Salama

  2. Departement of Chest Diseases, College of Medicine, Assiut University, Assiut, Egypt

    Maha M. Elkholy,  Samiaa Hamdy Sadek MD & Israa G. Mahdy

Authors
  1. Ragaa H. M. Salama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maha M. Elkholy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samiaa Hamdy Sadek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Israa G. Mahdy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samiaa Hamdy Sadek MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salama, R.H.M., Elkholy, M.M., Sadek, S.H. et al. Total antioxidant capacity as a marker in predicting severity of chronic obstructive pulmonary diseases. Egypt J Bronchol 11, 322–326 (2017). https://doi.org/10.4103/1687-8426.217638

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.217638

Keywords